Affinity DataIC50: 0.0600nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.670nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.670nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.10nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.10nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9.40nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9.40nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair